Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Aimmune Therapeutics, Inc.Listing unverified | Buy | $32M | conv 37First in 12mo | SEC | |
Aimmune Therapeutics, Inc.Listing unverified | Other | $84.7M | SEC | ||
Aimmune Therapeutics, Inc.Listing unverified | Other | $205M | SEC | ||
Aimmune Therapeutics, Inc.Listing unverified | Buy | $168M | conv 58First in 12mo | SEC | |
Seres Therapeutics, Inc.Listing on record | Award | $24M | SEC | ||
Seres Therapeutics, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Seres Therapeutics, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |